Go Pro

Veritone (VERI) Competitors

Veritone logo
$1.37 +0.06 (+4.58%)
Closing price 06/30/2026 04:00 PM Eastern
Extended Trading
$1.36 -0.02 (-1.09%)
As of 06/30/2026 07:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

VERI vs. BWMN, MNTN, EVH, CTEV, and NEXN

Should you buy Veritone stock or one of its competitors? MarketBeat compares Veritone with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Veritone include Bowman Consulting Group (BWMN), MNTN (MNTN), Evolent Health (EVH), Claritev (CTEV), and Nexxen International (NEXN). These companies are all part of the "business services" industry.

How does Veritone compare to Bowman Consulting Group?

Veritone (NASDAQ:VERI) and Bowman Consulting Group (NASDAQ:BWMN) are both small-cap business services companies, but which is the better business? We will compare the two companies based on the strength of their valuation, dividends, profitability, institutional ownership, risk, analyst recommendations, earnings and media sentiment.

In the previous week, Veritone had 31 more articles in the media than Bowman Consulting Group. MarketBeat recorded 34 mentions for Veritone and 3 mentions for Bowman Consulting Group. Bowman Consulting Group's average media sentiment score of 1.30 beat Veritone's score of 0.10 indicating that Bowman Consulting Group is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Veritone
1 Very Positive mention(s)
2 Positive mention(s)
30 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Bowman Consulting Group
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Bowman Consulting Group has higher revenue and earnings than Veritone. Veritone is trading at a lower price-to-earnings ratio than Bowman Consulting Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Veritone$92.19M1.38-$111.73M-$0.46N/A
Bowman Consulting Group$490.02M1.04$12.85M$0.6048.67

Bowman Consulting Group has a net margin of 2.02% compared to Veritone's net margin of -117.88%. Bowman Consulting Group's return on equity of 3.98% beat Veritone's return on equity.

Company Net Margins Return on Equity Return on Assets
Veritone-117.88% -198.79% -36.80%
Bowman Consulting Group 2.02%3.98%1.84%

39.2% of Veritone shares are owned by institutional investors. Comparatively, 63.2% of Bowman Consulting Group shares are owned by institutional investors. 7.4% of Veritone shares are owned by company insiders. Comparatively, 17.5% of Bowman Consulting Group shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Veritone has a beta of 2.23, meaning that its stock price is 123% more volatile than the broader market. Comparatively, Bowman Consulting Group has a beta of 1.33, meaning that its stock price is 33% more volatile than the broader market.

Veritone presently has a consensus target price of $7.38, suggesting a potential upside of 438.32%. Bowman Consulting Group has a consensus target price of $47.50, suggesting a potential upside of 62.67%. Given Veritone's stronger consensus rating and higher possible upside, research analysts clearly believe Veritone is more favorable than Bowman Consulting Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Veritone
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40
Bowman Consulting Group
1 Sell rating(s)
2 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.33

Summary

Bowman Consulting Group beats Veritone on 10 of the 15 factors compared between the two stocks.

How does Veritone compare to MNTN?

MNTN (NYSE:MNTN) and Veritone (NASDAQ:VERI) are both small-cap business services companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, institutional ownership, dividends, profitability, media sentiment, analyst recommendations, earnings and valuation.

72.9% of MNTN shares are owned by institutional investors. Comparatively, 39.2% of Veritone shares are owned by institutional investors. 19.6% of MNTN shares are owned by insiders. Comparatively, 7.4% of Veritone shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

In the previous week, Veritone had 30 more articles in the media than MNTN. MarketBeat recorded 34 mentions for Veritone and 4 mentions for MNTN. MNTN's average media sentiment score of 0.12 beat Veritone's score of 0.10 indicating that MNTN is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
MNTN
0 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Veritone
1 Very Positive mention(s)
2 Positive mention(s)
30 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

MNTN presently has a consensus price target of $19.85, indicating a potential upside of 116.68%. Veritone has a consensus price target of $7.38, indicating a potential upside of 438.32%. Given Veritone's higher probable upside, analysts plainly believe Veritone is more favorable than MNTN.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
MNTN
1 Sell rating(s)
2 Hold rating(s)
8 Buy rating(s)
1 Strong Buy rating(s)
2.75
Veritone
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40

MNTN has a net margin of 7.84% compared to Veritone's net margin of -117.88%. MNTN's return on equity of 16.44% beat Veritone's return on equity.

Company Net Margins Return on Equity Return on Assets
MNTN7.84% 16.44% 13.03%
Veritone -117.88%-198.79%-36.80%

MNTN has higher revenue and earnings than Veritone. MNTN is trading at a lower price-to-earnings ratio than Veritone, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
MNTN$290.09M1.93-$6.43M-$0.03N/A
Veritone$92.19M1.38-$111.73M-$0.46N/A

Summary

MNTN beats Veritone on 13 of the 16 factors compared between the two stocks.

How does Veritone compare to Evolent Health?

Evolent Health (NYSE:EVH) and Veritone (NASDAQ:VERI) are both small-cap business services companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, risk, dividends, valuation, institutional ownership, profitability, earnings and analyst recommendations.

Evolent Health has a beta of 0.84, suggesting that its stock price is 16% less volatile than the broader market. Comparatively, Veritone has a beta of 2.23, suggesting that its stock price is 123% more volatile than the broader market.

Evolent Health has a net margin of -26.29% compared to Veritone's net margin of -117.88%. Evolent Health's return on equity of 0.36% beat Veritone's return on equity.

Company Net Margins Return on Equity Return on Assets
Evolent Health-26.29% 0.36% 0.10%
Veritone -117.88%-198.79%-36.80%

Veritone has lower revenue, but higher earnings than Evolent Health. Veritone is trading at a lower price-to-earnings ratio than Evolent Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Evolent Health$1.88B0.32-$534.51M-$4.76N/A
Veritone$92.19M1.38-$111.73M-$0.46N/A

Evolent Health presently has a consensus price target of $6.08, indicating a potential upside of 13.06%. Veritone has a consensus price target of $7.38, indicating a potential upside of 438.32%. Given Veritone's higher probable upside, analysts plainly believe Veritone is more favorable than Evolent Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Evolent Health
1 Sell rating(s)
4 Hold rating(s)
12 Buy rating(s)
0 Strong Buy rating(s)
2.65
Veritone
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40

39.2% of Veritone shares are owned by institutional investors. 1.5% of Evolent Health shares are owned by company insiders. Comparatively, 7.4% of Veritone shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

In the previous week, Veritone had 33 more articles in the media than Evolent Health. MarketBeat recorded 34 mentions for Veritone and 1 mentions for Evolent Health. Evolent Health's average media sentiment score of 0.50 beat Veritone's score of 0.10 indicating that Evolent Health is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Evolent Health
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Veritone
1 Very Positive mention(s)
2 Positive mention(s)
30 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Evolent Health and Veritone tied by winning 8 of the 16 factors compared between the two stocks.

How does Veritone compare to Claritev?

Claritev (NYSE:CTEV) and Veritone (NASDAQ:VERI) are both small-cap business services companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, analyst recommendations, dividends, media sentiment, institutional ownership, earnings, valuation and profitability.

Claritev has a net margin of -29.27% compared to Veritone's net margin of -117.88%. Claritev's return on equity of 0.00% beat Veritone's return on equity.

Company Net Margins Return on Equity Return on Assets
Claritev-29.27% N/A -4.36%
Veritone -117.88%-198.79%-36.80%

Veritone has lower revenue, but higher earnings than Claritev. Veritone is trading at a lower price-to-earnings ratio than Claritev, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Claritev$965.41M0.61-$284.28M-$17.33N/A
Veritone$92.19M1.38-$111.73M-$0.46N/A

In the previous week, Veritone had 32 more articles in the media than Claritev. MarketBeat recorded 34 mentions for Veritone and 2 mentions for Claritev. Claritev's average media sentiment score of 0.48 beat Veritone's score of 0.10 indicating that Claritev is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Claritev
0 Very Positive mention(s)
2 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Veritone
1 Very Positive mention(s)
2 Positive mention(s)
30 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Claritev has a beta of 0.77, indicating that its share price is 23% less volatile than the broader market. Comparatively, Veritone has a beta of 2.23, indicating that its share price is 123% more volatile than the broader market.

Claritev currently has a consensus target price of $33.67, suggesting a potential downside of 1.99%. Veritone has a consensus target price of $7.38, suggesting a potential upside of 438.32%. Given Veritone's higher probable upside, analysts plainly believe Veritone is more favorable than Claritev.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Claritev
1 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.57
Veritone
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40

87.2% of Claritev shares are held by institutional investors. Comparatively, 39.2% of Veritone shares are held by institutional investors. 7.4% of Claritev shares are held by company insiders. Comparatively, 7.4% of Veritone shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Summary

Claritev beats Veritone on 10 of the 16 factors compared between the two stocks.

How does Veritone compare to Nexxen International?

Nexxen International (NASDAQ:NEXN) and Veritone (NASDAQ:VERI) are both small-cap business services companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, dividends, media sentiment, risk, profitability, earnings and institutional ownership.

Nexxen International currently has a consensus price target of $11.17, suggesting a potential upside of 23.66%. Veritone has a consensus price target of $7.38, suggesting a potential upside of 438.32%. Given Veritone's higher probable upside, analysts clearly believe Veritone is more favorable than Nexxen International.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Nexxen International
0 Sell rating(s)
2 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.80
Veritone
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40

Nexxen International has higher revenue and earnings than Veritone. Veritone is trading at a lower price-to-earnings ratio than Nexxen International, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Nexxen International$364.78M1.39$25.04M$0.3030.10
Veritone$92.19M1.38-$111.73M-$0.46N/A

Nexxen International has a net margin of 4.85% compared to Veritone's net margin of -117.88%. Nexxen International's return on equity of 7.78% beat Veritone's return on equity.

Company Net Margins Return on Equity Return on Assets
Nexxen International4.85% 7.78% 4.94%
Veritone -117.88%-198.79%-36.80%

Nexxen International has a beta of 1.64, meaning that its stock price is 64% more volatile than the broader market. Comparatively, Veritone has a beta of 2.23, meaning that its stock price is 123% more volatile than the broader market.

54.2% of Nexxen International shares are owned by institutional investors. Comparatively, 39.2% of Veritone shares are owned by institutional investors. 7.4% of Veritone shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

In the previous week, Veritone had 32 more articles in the media than Nexxen International. MarketBeat recorded 34 mentions for Veritone and 2 mentions for Nexxen International. Nexxen International's average media sentiment score of 1.09 beat Veritone's score of 0.10 indicating that Nexxen International is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Nexxen International
0 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Veritone
1 Very Positive mention(s)
2 Positive mention(s)
30 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Nexxen International beats Veritone on 12 of the 16 factors compared between the two stocks.

Get Veritone News Delivered to You Automatically

Sign up to receive the latest news and ratings for VERI and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding VERI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

VERI vs. The Competition

MetricVeritoneTechnology Services IndustryBusiness SectorNASDAQ Exchange
Market Cap$121.77M$4.22B$6.83B$12.45B
Dividend YieldN/A2.09%3.16%6.16%
P/E Ratio-2.9842.4330.2624.87
Price / Sales1.3847.80364.40102.84
Price / CashN/A37.0523.5658.59
Price / Book1.854.755.896.54
Net Income-$111.73M$31.79M$203.69M$336.70M
7 Day Performance2.24%0.90%0.86%2.88%
1 Month Performance-34.13%-10.15%-4.57%0.64%
1 Year Performance-2.14%21.52%26.62%31.34%

Veritone Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
VERI
Veritone
2.0079 of 5 stars
$1.37
+4.6%
$7.38
+438.3%
+8.7%$121.77M$92.19MN/A550
BWMN
Bowman Consulting Group
3.8722 of 5 stars
$29.65
-1.8%
$47.50
+60.2%
+1.6%$528.38M$490.02M49.422,300
MNTN
MNTN
4.2019 of 5 stars
$7.97
-4.6%
$19.85
+149.2%
-58.1%$509.46M$290.09MN/A502
EVH
Evolent Health
1.9827 of 5 stars
$4.49
+0.0%
$6.08
+35.3%
-52.5%$505.04M$1.88BN/A4,200
CTEV
Claritev
1.438 of 5 stars
$28.97
-1.5%
$33.67
+16.2%
-21.2%$501.55M$965.41MN/A3,000

Related Companies and Tools


This page (NASDAQ:VERI) was last updated on 7/1/2026 by MarketBeat.com Staff.
From Our Partners